Literature DB >> 12649739

Coordinated regulation and colocalization of alphav integrin and its activating enzyme proprotein convertase PC5 in vivo.

Philipp Stawowy1, Kristof Graf, Stephan Goetze, Mattias Roser, Michel Chrétien, Nabil G Seidah, Eckart Fleck, Mieczyslaw Marcinkiewicz.   

Abstract

Integrin alphav is involved in intracellular-extracellular signaling important for cytoskeleton alterations and control of cell movement. In vitro experiments indicate that the integrin alphav-subunit undergoes post-translational endoproteolytic cleavage. This type of activation requires the presence of suitable kexin/subtilisin-like proprotein convertases. In vitro experiments have demonstrated that, among several proprotein convertases, PC5A, and to a threefold lesser extent furin, can activate alphav integrin. The biological significance of these in vitro data would be further supported by a coexpression and coordinated regulation of the gene expression of alphav integrin and its activating enzyme PC5 in vivo. In the present study we investigated the regulation of alphav integrin and PC5 following balloon injury in vivo. Comparative immunocytochemistry revealed a coordinated regulation of alphav integrin and PC5 during vascular remodeling in rodents. Integrin alphav was found to be upregulated in PCNA-positive, proliferating vascular smooth muscle cells. Northern blots revealed no significant regulation of furin mRNA, whereas PC5A mRNA increased during vascular remodeling, suggesting that PC5 is the major convertase during neointima formation in vivo. Incubation of vascular smooth muscle cells with the Golgi-disturbing agent brefeldin A inhibited alphav integrin maturation, indicating that endoproteolytic cleavage occurs in the trans-Golgi network, were PC5 is localized. Thus, the present study further supports the concept that activation of alphav integrin occurs in the trans-Golgi network in vascular smooth muscle cells and involves PC5.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649739     DOI: 10.1007/s00418-003-0506-7

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  27 in total

Review 1.  The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development.

Authors:  B P Eliceiri; D A Cheresh
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 2.  The smooth muscle cell in culture.

Authors:  J Chamley-Campbell; G R Campbell; R Ross
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

3.  Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7.

Authors:  J C Lissitzky; J Luis; J S Munzer; S Benjannet; F Parat; M Chrétien; J Marvaldi; N G Seidah
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

4.  Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA.

Authors:  E T Choi; L Engel; A D Callow; S Sun; J Trachtenberg; S Santoro; U S Ryan
Journal:  J Vasc Surg       Date:  1994-01       Impact factor: 4.268

5.  Cleavage of the alpha6A subunit is essential for activation of the alpha6Abeta1 integrin by phorbol 12-myristate 13-acetate.

Authors:  G O Delwel; F Hogervorst; A Sonnenberg
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

6.  Differential mRNA regulation of integrin subunits alpha V, beta 1, beta 3, and beta 5 during mouse embryonic organogenesis.

Authors:  S Yamada; K E Brown; K M Yamada
Journal:  Cell Adhes Commun       Date:  1995-11

Review 7.  Regulation of differentiation of vascular smooth muscle cells.

Authors:  G K Owens
Journal:  Physiol Rev       Date:  1995-07       Impact factor: 37.312

8.  Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation.

Authors:  H Matsuno; J M Stassen; J Vermylen; H Deckmyn
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

9.  Alpha-v beta-3 integrin expression in normal and atherosclerotic artery.

Authors:  M Hoshiga; C E Alpers; L L Smith; C M Giachelli; S M Schwartz
Journal:  Circ Res       Date:  1995-12       Impact factor: 17.367

10.  cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors.

Authors:  S Suzuki; W S Argraves; R Pytela; H Arai; T Krusius; M D Pierschbacher; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more
  7 in total

Review 1.  Innovative techniques and applications in histochemistry and cell biology.

Authors:  Esther Asan
Journal:  Histochem Cell Biol       Date:  2003-11-28       Impact factor: 4.304

2.  The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases.

Authors:  Nadia Nour; Gaétan Mayer; John S Mort; Alexandre Salvas; Majambu Mbikay; Charlotte J Morrison; Christopher M Overall; Nabil G Seidah
Journal:  Mol Biol Cell       Date:  2005-08-31       Impact factor: 4.138

Review 3.  Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels.

Authors:  Philipp Stawowy; Eckart Fleck
Journal:  J Mol Med (Berl)       Date:  2005-10-22       Impact factor: 4.599

Review 4.  The proprotein convertases are potential targets in the treatment of dyslipidemia.

Authors:  Nabil G Seidah; Annik Prat
Journal:  J Mol Med (Berl)       Date:  2007-03-10       Impact factor: 4.599

5.  Immunohistochemical localization of subtilisin/kexin-like proprotein convertases in human atherosclerosis.

Authors:  Philipp Stawowy; Heike Kallisch; Núbia Borges Pereira Stawowy; Dietger Stibenz; John P Veinot; Michael Gräfe; Nabil G Seidah; Michel Chrétien; Eckart Fleck; Kristof Graf
Journal:  Virchows Arch       Date:  2005-03-09       Impact factor: 4.064

6.  SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity.

Authors:  Lee B Rivera; Rolf A Brekken
Journal:  J Cell Biol       Date:  2011-06-27       Impact factor: 10.539

7.  Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease.

Authors:  Bianca E Suur; Melody Chemaly; Moritz Lindquist Liljeqvist; Djordje Djordjevic; Markus Stenemo; Otto Bergman; Eva Karlöf; Mariette Lengquist; Jacob Odeberg; Eva Hurt-Camejo; Per Eriksson; Daniel F J Ketelhuth; Joy Roy; Ulf Hedin; Michael Nyberg; Ljubica Matic
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.